Cargando…

Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p

Rationale: Glioma stem-like cells (GSCs) contribute to temozolomide (TMZ) resistance in gliomas, although the mechanisms have not been delineated. Methods: In vitro functional experiments (colony formation assay, flow cytometric analysis, TUNEL assay) were used to assess the ability of extracellular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Jianxing, Ge, Xin, Shi, Zhumei, Yu, Chen, Lu, Chenfei, Wei, Yutian, Zeng, Ailiang, Wang, Xiefeng, Yan, Wei, Zhang, Junxia, You, Yongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778586/ https://www.ncbi.nlm.nih.gov/pubmed/33408780 http://dx.doi.org/10.7150/thno.47057

Ejemplares similares

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
por: Lu, Chenfei, et al.
Publicado: (2020)

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma
por: Zhang, Zhuoran, et al.
Publicado: (2019)

Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma
por: Yin, Jianxing, et al.
Publicado: (2019)

MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism
por: Yin, JianXing, et al.
Publicado: (2020)

EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1–2 signaling
por: Wei, Yutian, et al.
Publicado: (2020)

Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis
por: Yu, Cheng, et al.
Publicado: (2020)

Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas
por: Yin, Jianxing, et al.
Publicado: (2023)

METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling
por: Yin, Jianxing, et al.
Publicado: (2023)

Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma
por: Nie, Er, et al.
Publicado: (2018)

BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
por: Nie, Er, et al.
Publicado: (2016)

SP1-upregulated LBX2-AS1 promotes the progression of glioma by targeting the miR-491-5p/LIF axis
por: Li, Wentao, et al.
Publicado: (2021)

TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT
por: Nie, Er, et al.
Publicado: (2020)

MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53
por: Zhou, Xu, et al.
Publicado: (2017)

EZH2 alteration driven by microRNA-524-5p and microRNA-324-5p promotes cell proliferation and temozolomide resistance in glioma
por: Zhi, Tongle, et al.
Publicado: (2017)

Genome-wide identification of epithelial-mesenchymal transition-associated microRNAs reveals novel targets for glioblastoma therapy
por: Zhang, Yong, et al.
Publicado: (2018)

Glioblastoma-Derived Extracellular Vesicles Facilitate Transformation of Astrocytes via Reprogramming Oncogenic Metabolism
por: Zeng, Ailiang, et al.
Publicado: (2020)

Molecular Characterization of Temozolomide-Treated and Non Temozolomide-Treated Glioblastoma Cells Released Extracellular Vesicles and Their Role in the Macrophage Response
por: Panzarini, Elisa, et al.
Publicado: (2020)

Serum-derived extracellular vesicles facilitate temozolomide resistance in glioblastoma through a HOTAIR-dependent mechanism
por: Wang, Xiaosong, et al.
Publicado: (2022)

Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma
por: Chen, Kai, et al.
Publicado: (2022)

Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma
por: Liu, Xiao, et al.
Publicado: (2023)

Glioblastoma-Derived Small Extracellular Vesicles: Nanoparticles for Glioma Treatment
por: Araujo-Abad, Salomé, et al.
Publicado: (2023)

PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma
por: Yang, Eryan, et al.
Publicado: (2022)

Cyclooxygenase-2 Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In Extracellular Vesicles Modifying Recipient Cell Phenotype
por: Lombardi, Francesca, et al.
Publicado: (2022)

Immunomodulatory effects of extracellular vesicles in glioblastoma
por: Low, Johannes Jun Wei, et al.
Publicado: (2022)

NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells
por: Han, Dongfeng, et al.
Publicado: (2015)

MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype
por: Yan, Wei, et al.
Publicado: (2015)

Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide
por: Ding, Yiming, et al.
Publicado: (2021)

Proteomics of Extracellular Vesicle in Glioblastoma
por: Lee, Yoon-Jin, et al.
Publicado: (2022)

Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
por: Rao, Jyotsna U., et al.
Publicado: (2017)

Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics
por: Li, Rui, et al.
Publicado: (2015)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Polycomb group expression signatures in the malignant progression of gliomas
por: Hu, Qi, et al.
Publicado: (2017)

The Immunomodulatory Role of Hypoxic Tumor-Derived Extracellular Vesicles
por: Beaumont, Joel E. J., et al.
Publicado: (2022)

miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma
por: Zeng, Ailiang, et al.
Publicado: (2018)

Extracellular Vesicles in Glioblastoma Tumor Microenvironment
por: Yekula, Anuroop, et al.
Publicado: (2020)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Structural alterations of the salience network in patients with insular glioma
por: Hu, Guanjie, et al.
Publicado: (2023)

Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide
por: Yan, Tao, et al.
Publicado: (2011)

Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma
por: Bikhezar, Fatima, et al.
Publicado: (2019)

HSP90B1-mediated plasma membrane localization of GLUT1 promotes radioresistance of glioblastomas
por: Li, Yanhui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5bbv40ejrgbr9gd9lvlk7vb2tb